ProZema (30 doses)

ProZema has been clinically shown to reduce the symptoms of eczema and atopic dermatitis within 12 weeks. In the trial, patients were able to stop the use of corticosteroids after 6 weeks of taking ProZema.

The SCORAD index value measures the severity of atopic dermatitis. Higher index values mean severe cases, while lower index values mean mild cases.

A single-center, randomized, double-blind clinical research trial was carried out. In this trial, 96% of patients in the probiotic group improved their SCORAD index values. This means the severity of atopic dermatitis was reduced.

The reduction in severity was measured. In the probiotic group, patients displayed an 84% reduction in SCORAD index values. This means the SCORAD scores changed from higher to lower values.

In 91% of patients the symptoms of atopic dermatitis had cleared or almost cleared within 12 weeks.

ProZema is a natural treatment option for patients of eczema and atopic dermatitis. As an adjunct therapy, ProZema fits into curated treatment plans. Please discuss any changes to your treatment plan with your healthcare practitioner first.

Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, et al. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2018;154(1):37-43.